Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in pediatric patients.

PLoS One · 2025 · PMC12483236 · PMID 41026784

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The increase of odds ratio by 144.5% for each unit increase in L-FABP, couples with a highly significant p-value of less than 0.0001, underscores the robustness of L-FABP as a biomarker for MASLD diagnosis.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.